Last Close
121.81 $
Jul 3, 26
Market Cap
41.1 B $
Q2 2025 (TTM)
52-Week Range
%-48.2
%39.5
-2.46
-2.08
%-54.1
-%65.3
1M
+32.1%
3M
-12.3%
6M
-28.3%
YTD
-28.5%
1Y
-48.2%
3Y
-53.5%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P/ASX 200 index is measured in its own currency.
CSL last closed at 121.81 $ (Jul 3, 26). Price data is refreshed after every trading day.
CSL Ltd trades at a trailing-twelve-month P/E of 29.44. See the comparison tables on the Peers tab for the industry context.
CSL Ltd (CSL) has a market capitalization of approximately 41.1 B $ as of the latest reported period.
Key peers of CSL Ltd include Roivant Sciences Ltd, Moderna Inc, Royalty Pharma Plc, Incyte Corporation, Insmed Inc. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.